Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

162
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

GlaxoSmithKline: European Commission Authorizes Nimenix

04/27/2012 | 08:24am US/Eastern

GlaxoSmithKline PLC (>> GlaxoSmithKline plc), the drug company, said Friday that the European Commission has granted marketing authorization for Nimenrix, Meningococcal group A, C, W-135 and Y conjugate vaccine, for active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135 and Y.

-Shares at 1207 GMT, up a penny, or 0.04%, at 1,420.5 pence valuing the company at GBP71.61 billion.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
React to this article
Latest news on GLAXOSMITHKLINE PLC
2d ago GLAXOSMITHKLINE : Assigned Patent
3d ago GSK shareholders approve asset swap deal with Novartis
3d agoDJGLAXOSMITHKLINE : Glaxo : Study of Shingles Vaccine Meets Primary Objective
3d ago GLAXOSMITHKLINE : Glaxo Says Phase III Shingles Candidate Vaccine Trial Met Endp..
3d ago GLAXOSMITHKLINE : Pivotal phase III study of GSK shingles candidate vaccine meet..
4d agoDJFrance Told To Do More for Foreign Investors
5d ago Drop in inflation helps FTSE shrug off Russia turmoil
5d ago GLAXOSMITHKLINE : New European consortium formed to help further advance develop..
12/12 GLAXOSMITHKLINE : Assigned Patent
12/12 GLAXOSMITHKLINE : Ebola vaccine trial halted
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF